Collection 專利 [0/4] 期刊論文 [330/333] 圖書 [1/1] 會議論文/會議摘要 [116/180] Siblings 于重元 [19/19] 劉柯俊 [87/107] 劉滄梧 [120/126] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [85/97] 常慧如 [40/45] 張俊彥 [234/254] 張光裕 [70/80] 張憶壽 [104/107] 張文祥 [52/54] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/47] 李家惠 [29/29] 李岳倫 [49/55] 林素芳 [32/32] 楊奕馨 [44/45] 江士昇 [90/92] 沈哲宏 [14/16] 洪文俊 [88/92] 莊雙恩 [82/91] 蔡坤志 [32/35] 蔡慧珍 [67/85] 蘇勇曄 [41/41] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [46/49] 陳振陽 [72/72] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [39/40] 黃智興 [56/57] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [470/478] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/56] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Community Statistics 近3年內發表的文件:43(8.30%) 含全文筆數:447(86.29%) 文件下載次數統計 下載大於0次:447(100.00%) 下載大於100次:431(96.42%) 檔案下載總次數:184360(3.25%) 最後更新時間: 2025-02-20 14:41 Top Upload Loading... Top Download Loading... Recent Submissions 単離抗体,医薬組成物,単離抗体結合体,ダイマー化阻害方法,シグナル伝達... 可標靶ＶＥＧＦＲ２與ＶＥＧＦＲ３的雙功能抗體 Dual-function antibodies targeting ... Dual-function antibodies targeting ... Pan-Asian adapted ESMO clinical pra... Perspectives of the medical oncolog... TCOG T3221 study: The registry of g... Cooperative participation of CagA a... Pan-Asian adapted ESMO clinical pra... Nivolumab plus chemotherapy in pati...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 191-200 of 518. (52 Page(s) Totally) << < 15 16 17 18 19 20 21 22 23 24 > >> View [10|25|50] records per page

Date	Title	Relation
2018-08-24	BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor	Cancer Science. 2018 Nov;109(11):3591-3601.
2018-07	The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients	Journal of the Chinese Medical Association. 2018 Jul;81(7):593-598.
2018-06	Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2018 Jun;29(6):1402-1408.
2018-06	The effect of best response to prior anticancer therapy on efficacy outcomes in the napoli-1 trial of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy	Annals of Oncology. 2018 Jun;29(Suppl. 5):Meeting Abstract P-152.
2018-06	Decreased appetite (DA) at baseline impacts prognosis in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)	Annals of Oncology. 2018 Jun;29(Suppl. 5):Meeting Abstract P-153.
2018-06	Prognostic effect of primary tumor location in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)	Annals of Oncology. 2018 Jun;29(Suppl. 5):Meeting Abstract P-150.
2018-06	Selected subgroup analyses of liposomal irinotecan (nal-IRI) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the global NAPOLI-1 phase III trial	Annals of Oncology. 2018 Jun;29(Suppl. 5):Meeting Abstract O-004.
2018-06	Prognostic value of baseline biliary stents on outcomes in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the NAPOLI-1 trial	Annals of Oncology. 2018 Jun;29(Suppl. 5):Meeting Abstract P-151.
2018-05	Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials	Journal of Clinical Oncology. 2018 May;36(15, Suppl.):Abstract number e15127.
2018-05	A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers	Journal of Clinical Oncology. 2018 May;36(15, Suppl. S):Meeting Abstract 2556.

Showing items 191-200 of 518. (52 Page(s) Totally) << < 15 16 17 18 19 20 21 22 23 24 > >> View [10|25|50] records per page